Alvotech And JAMP Partner On Canadian Biosimilars
Partnership Covers Five Alvotech Biosimilar Candidates
Executive Summary
Alvotech and JAMP Pharma have struck a partnership deal to market five biosimilars in Canada that have a combined current branded market value of more than $2bn annually.